Many psychiatric drugs act on the receptors or transporters of certain neurotransmitters in the brain. However, there is a great need for alternatives, and research is looking at other targets along the brain's metabolic pathways. Lack of glycine betaine contributes to brain pathology in schizophrenia, and new research shows that betaine supplementation can counteract psychiatric symptoms in mice.
from Latest Science News -- ScienceDaily https://ift.tt/2YjF8H4
via IFTTT
Thursday, June 27, 2019
Boosting amino acid derivative may be a treatment for schizophrenia
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment